Submission Details
| 510(k) Number | K223394 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 08, 2022 |
| Decision Date | December 07, 2022 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
K223394 is an FDA 510(k) clearance for the Visionary Optics Scleral Contact Lens (roflufocon D, roflufocon E, hexafocon A, hexafocon B, tisilfocon A), a Lens, Contact (other Material) - Daily (Class II — Special Controls, product code HQD), submitted by Visionary Optics, LLC (Front Royal, US). The FDA issued a Cleared decision on December 7, 2022, 29 days after receiving the submission on November 8, 2022. This device falls under the Ophthalmic review panel. Regulated under 21 CFR 886.5916.
| 510(k) Number | K223394 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 08, 2022 |
| Decision Date | December 07, 2022 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
| Product Code | HQD — Lens, Contact (other Material) - Daily |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 886.5916 |